Glycopeptide-Intermediate Staphylococcus aureus: Evaluation of a Novel Screening Method and Results of a Survey of Selected U.S. Hospitals

Isolates of Staphylococcus aureus with decreased susceptibilities to glycopeptide antimicrobial agents, such as vancomycin and teicoplanin, have emerged in the United States and elsewhere. Commercially prepared brain heart infusion agar (BHIA) supplemented with 6 μg of vancomycin per ml was shown in...

Descripción completa

Detalles Bibliográficos

Publicado en:	J Clin Microbiol
Autores principales:	Hubert, Susannah K., Mohammed, Jasmine M., Fridkin, Scott K., Gaynes, Robert P., McGowan, John E., Tenover, Fred C.
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	American Society for Microbiology (ASM) 1999
Materias:	Bacteriology
Acceso en línea:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC85700/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/10523558/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/jcm.37.11.3590-3593.1999
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!